Ads
related to: diabetes guidelines for providers 2 list of medications
Search results
Results from the WOW.Com Content Network
Diabetes medication. Drugs used in diabetes treat diabetes mellitus by decreasing glucose levels in the blood. With the exception of insulin, most GLP-1 receptor agonists ( liraglutide, exenatide, and others), and pramlintide, all diabetes medications are administered orally and are thus called oral hypoglycemic agents or oral antihyperglycemic ...
Diabetes management. The term diabetes includes several different metabolic disorders that all, if left untreated, result in abnormally high concentrations of a sugar called glucose in the blood. Diabetes mellitus type 1 results when the pancreas no longer produces significant amounts of the hormone insulin, usually owing to the autoimmune ...
The American Diabetes Association and the American College of Physicians both recommend metformin as a first-line agent to treat type 2 diabetes. [34] [35] [36] It is as effective as repaglinide and more effective than all other oral drugs for type 2 diabetes. [37]
4.2 million (2019) [ 9] Diabetes mellitus, often known simply as diabetes, is a group of common endocrine diseases characterized by sustained high blood sugar levels. [ 10][ 11] Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body becoming unresponsive to the hormone's effects. [ 12]
Alpha-glucosidase inhibitors ( AGIs) are oral anti-diabetic drugs used for diabetes mellitus type 2 that work by preventing the digestion of carbohydrates (such as starch and table sugar ). Carbohydrates are normally converted into simple sugars ( monosaccharides) by alpha-glucosidase enzymes present on cells lining the intestine, enabling ...
SGLT2 inhibitor. SGLT2 inhibitors (also called gliflozins or flozins) are a class of medications that inhibit sodium-glucose transport proteins in the nephron (the functional units of the kidney ), unlike SGLT1 inhibitors that perform a similar function in the intestinal mucosa. The foremost metabolic effect of this is to inhibit reabsorption ...
A new study, published in the journal JAMA Network Open, indicates that maintaining more stable hemoglobin A1c (HbA1c) levels over time in ranges tailored to individuals is associated with a lower ...
Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and works by increasing sugar loss in urine. [ 2] Empagliflozin was approved for medical use in the United States and in the European Union in 2014. [ 11][ 22][ 23] It is on the World Health Organization's List of Essential Medicines. [ 24]
Ads
related to: diabetes guidelines for providers 2 list of medications